title: Genetic Risk and Altering Lipids With Lifestyle Changes and Metformin: Is Fate Modifiable?
authors.affiliation: From the Department of Cardiology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. pereira.naveen@mayo.edu.
authors.forename: Naveen L
authors.initials: NL
authors.lastname: Pereira
mesh_terms: D003924:Diabetes Mellitus, Type 2; D007004:Hypoglycemic Agents; D008019:Life Style; D008055:Lipids; D008687:Metformin; D012307:Risk Factors
chemical_list: D007004:Hypoglycemic Agents; D008055:Lipids; D008687:Metformin
keywords: Editorials; cardiovascular disease; genetics; genome-wide association study; lipids; primary prevention